Literature DB >> 24824526

A spectroscopic investigation of the interaction between c-MYC DNA and tetrapyridinoporphyrazinatozinc(II).

Leila Hassani1, Zahra Fazeli, Elham Safaei, Hossein Rastegar, Minoo Akbari.   

Abstract

The c-MYC gene plays an important role in the regulation of cell proliferation and growth and it is overexpressed in a wide variety of human cancers. Around 90% of c-MYC transcription is controlled by the nuclease-hypersensitive element III1 (NHE III1), whose 27-nt purine-rich strand has the ability to form a G-quadruplex structure under physiological conditions. Therefore, c-MYC DNA is an attractive target for drug design, especially for cancer chemotherapy. Here, the interaction of water-soluble tetrapyridinoporphyrazinatozinc(II) with 27-nt G-rich strand (G/c-MYC), its equimolar mixture with the complementary sequence (GC/c-MYC) and related C-rich oligonucleotide (C/c-MYC) is investigated. Circular dichroism (CD) measurements of the G-rich 27-mer oligonucleotide in 150 mM KCl, pH 7 demonstrate a spectral signature consistent with parallel G-quadruplex DNA. Furthermore, the CD spectrum of the GC rich oligonucleotide shows characteristics of both duplex and quadruplex structures. Absorption spectroscopy implies that the complex binding of G/c-MYC and GC/c-MYC is a two-step process; in the first step, a very small red shift and hypochromicity and in the second step, a large red shift and hyperchromicity are observed in the Q band. Emission spectra of zinc porphyrazine are quenched upon addition of three types of DNA. According to the results of spectroscopy, it can be concluded the dominant binding mode is probably, outside binding and end stacking.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24824526      PMCID: PMC4059838          DOI: 10.1007/s10867-014-9348-x

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  21 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 2.  Circular dichroism and guanine quadruplexes.

Authors:  Michaela Vorlíčková; Iva Kejnovská; Janos Sagi; Daniel Renčiuk; Klára Bednářová; Jitka Motlová; Jaroslav Kypr
Journal:  Methods       Date:  2012-03-17       Impact factor: 3.608

Review 3.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

4.  Biophysical studies of the c-MYC NHE III1 promoter: model quadruplex interactions with a cationic porphyrin.

Authors:  Matthew W Freyer; Robert Buscaglia; Kimberly Kaplan; Derek Cashman; Laurence H Hurley; Edwin A Lewis
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

5.  DNA tetraplex formation in the control region of c-myc.

Authors:  T Simonsson; P Pecinka; M Kubista
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

Review 6.  Structural insights into G-quadruplexes: towards new anticancer drugs.

Authors:  Danzhou Yang; Keika Okamoto
Journal:  Future Med Chem       Date:  2010-04       Impact factor: 3.808

7.  Targeting MYC Expression through G-Quadruplexes.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Genes Cancer       Date:  2010-06

Review 8.  Action of Myc in vivo - proliferation and apoptosis.

Authors:  S Pelengaris; B Rudolph; T Littlewood
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

9.  Thermodynamics of interactions of water-soluble porphyrins with RNA duplexes.

Authors:  Ara A Ghazaryan; Yeva B Dalyan; Samvel G Haroutiunian; Anna Tikhomirova; Nicolas Taulier; James W Wells; Tigran V Chalikian
Journal:  J Am Chem Soc       Date:  2006-02-15       Impact factor: 15.419

10.  Effect of Ionic Strength on Porphyrin Drugs Interaction with Quadruplex DNA Formed by the Promoter Region of C-myc and Bcl2 Oncogenes.

Authors:  Narayana Nagesh; Varun K Sharma; A Ganesh Kumar; Edwin A Lewis
Journal:  J Nucleic Acids       Date:  2009-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.